KRecwvaS MHecct es PA. tees A033 354 REPOSIT!oryCenter Germintowr nd . COLLECTION BOX No. Col Oc it. ladt TS. - Cclecsi fied Feb/mar i194 | uo ————— ae , he bebeee a FOLDEA [omane Ths dommmens cotsisls cH ae DR. JOHN C. BUQHER, MD, DIRECTOR DIVISION OF BIOLOGY AND MEDICINE ATOMIC ENERGY COMMISSION WASHINOTON, De Ce 1, asst ceca, PRIORITY BEST COPY AVAILABLE VIA SECRETARY OF STATE mse os JOHN ALLISON AMBASSADOR U. S. EMGASSY TOKYO INFO: OR. JOHN J. MORTON, JR. AND MR. MERRIL KISENDUD BEUR 2380 APRIL 1 NOON. IM VIEW ANTAGONISTIC ATTITUDE JAPAIESE PHYSICIANS AND SCIENTISTS AS SHOWN IN THEIR REFISAL TO PERMIT AMERICAN HEVIEW AND PARTICIPATION TB CLINICAL STUDIES, FEEL THAT MO ADWICE RELATIVE TREATMENT CAN BE GIVEN ON HEARSAY INFORMATION. SITUATION APPEARS TO US PREDOMINENTLY DIPLOMATIC WITH THJURED FISHERMEN PAWNS IN MORE ELABORATE GAME. SUGGEST THAT JAPANESE OFFI~ CIALS BE INFORMED THAT FURTHER U. S. MEDICAL INTEREST WILL BE CONDITIONED ON: Le IMMEDIATE AMD FULL COOPERATION IN ALL MEDICAL AND SCIENTIFIC ASPECTS, INCLUDING COMPLETE ACCESS TO ALL IMDIVIDUALS AFFECTED. @. UNAESTRICTED AND CAREFUL DEVELOPMENT OF DETAILED CLINICAL DATA IMq CLUDING AT LEAST THE FOLLOWING: (#8) MINIMAL DAILY BLOOD STUDIES TO DNCLUDE HED BLOOD CELL COUNT, HEMAOQLOHIN, HEMATOCRIT, TOTAL WHITE BLOOD CELL COUN, DIFFERENTIAL WHITE COUNT AND PLATELETS HEPEAT PLATELETS. 522) BOBROWN:mlh 1630 pom x61] , _ 2 of wt PoE,oeOEeison Oegeeceibibhereshisn 0000350 . (b) R&ECAPITULATION noEaaw eo cr oa ,